Literature DB >> 19840946

PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis.

Ognian C Ikonomov1, Diego Sbrissa, Homer Fenner, Assia Shisheva.   

Abstract

The phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P(2)) metabolizing enzymes, the kinase PIKfyve and the phosphatase Sac3, constitute a single multiprotein complex organized by the PIKfyve regulator ArPIKfyve and its ability to homodimerize. We previously established that PIKfyve is activated within the triple PIKfyve-ArPIKfyve-Sac3 (PAS) core. These data assign an atypical function for the phosphatase in PtdIns(3,5)P(2) biosynthesis, thus raising the question of whether Sac3 retains its PtdIns(3,5)P(2) hydrolyzing activity within the PAS complex. Herein, we address the issue of Sac3 functionality by a combination of biochemical and morphological assays in triple-transfected COS cells using a battery of truncated or point mutants of the three proteins. We identified the Cpn60_TCP1 domain of PIKfyve as a major determinant for associating the ArPIKfyve-Sac3 subcomplex. Neither Sac3 nor PIKfyve enzymatic activities affected the PAS complex formation or stability. Using the well established formation of aberrant cell vacuoles as a sensitive functional measure of localized PtdIns(3,5)P(2) reduction, we observed a mitigated vacuolar phenotype by kinase-deficient PIKfyve(K1831E) if its ArPIKfyve-Sac3 binding region was deleted, suggesting reduced Sac3 access to, and turnover of PtdIns(3,5)P(2). In contrast, PIKfyve(K1831E), which displays intact ArPIKfyve-Sac3 binding, triggered a more severe vacuolar phenotype if coexpressed with ArPIKfyve(WT)-Sac3(WT) but minimal defects when coexpressed with ArPIKfyve(WT) and phosphatase-deficient Sac3(D488A). These data indicate that Sac3 assembled in the PAS regulatory core complex is an active PtdIns(3,5)P(2) phosphatase. Based on these and other data, presented herein, we propose a model of domain interactions within the PAS core and their role in regulating the enzymatic activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840946      PMCID: PMC2791009          DOI: 10.1074/jbc.M109.037515

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  PIKfyve lipid kinase is a protein kinase: downregulation of 5'-phosphoinositide product formation by autophosphorylation.

Authors:  D Sbrissa; O C Ikonomov; A Shisheva
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

2.  Binding of Vac14 to neuronal nitric oxide synthase: Characterisation of a new internal PDZ-recognition motif.

Authors:  Jean-François Lemaire; Peter S McPherson
Journal:  FEBS Lett       Date:  2006-12-04       Impact factor: 4.124

Review 3.  PIKfyve: Partners, significance, debates and paradoxes.

Authors:  Assia Shisheva
Journal:  Cell Biol Int       Date:  2008-01-25       Impact factor: 3.612

4.  Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Assia Shisheva
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

5.  Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve.

Authors:  O C Ikonomov; D Sbrissa; A Shisheva
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

6.  Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J.

Authors:  Clement Y Chow; Yanling Zhang; James J Dowling; Natsuko Jin; Maja Adamska; Kensuke Shiga; Kinga Szigeti; Michael E Shy; Jun Li; Xuebao Zhang; James R Lupski; Lois S Weisman; Miriam H Meisler
Journal:  Nature       Date:  2007-06-17       Impact factor: 49.962

7.  ArPIKfyve-PIKfyve interaction and role in insulin-regulated GLUT4 translocation and glucose transport in 3T3-L1 adipocytes.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Rajeswari Dondapati; Assia Shisheva
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

8.  Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice.

Authors:  Yanling Zhang; Sergey N Zolov; Clement Y Chow; Shalom G Slutsky; Simon C Richardson; Robert C Piper; Baoli Yang; Johnathan J Nau; Randal J Westrick; Sean J Morrison; Miriam H Meisler; Lois S Weisman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

9.  Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Zhiyao Fu; Takeshi Ijuin; Jean Gruenberg; Tadaomi Takenawa; Assia Shisheva
Journal:  J Biol Chem       Date:  2007-06-07       Impact factor: 5.157

10.  A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding.

Authors:  Harold B J Jefferies; Frank T Cooke; Parmjit Jat; Christine Boucheron; Tomonobu Koizumi; Masahiko Hayakawa; Hiroyuki Kaizawa; Takahide Ohishi; Paul Workman; Michael D Waterfield; Peter J Parker
Journal:  EMBO Rep       Date:  2008-01-11       Impact factor: 8.807

View more
  35 in total

Review 1.  Phosphoinositides and vesicular membrane traffic.

Authors:  Peter Mayinger
Journal:  Biochim Biophys Acta       Date:  2012-01-14

Review 2.  Phosphatidylinositol 3,5-bisphosphate: low abundance, high significance.

Authors:  Amber J McCartney; Yanling Zhang; Lois S Weisman
Journal:  Bioessays       Date:  2013-10-28       Impact factor: 4.345

Review 3.  Endosome maturation.

Authors:  Jatta Huotari; Ari Helenius
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

4.  The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation.

Authors:  Christin Bissig; Pauline Croisé; Xavier Heiligenstein; Ilse Hurbain; Guy M Lenk; Emily Kaufman; Ragna Sannerud; Wim Annaert; Miriam H Meisler; Lois S Weisman; Graça Raposo; Guillaume van Niel
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

5.  Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.

Authors:  Diego Sbrissa; Ognian C Ikonomov; Catherine Filios; Khortnal Delvecchio; Assia Shisheva
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

6.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

7.  The Vac14-interaction network is linked to regulators of the endolysosomal and autophagic pathway.

Authors:  Ulf Schulze; Beate Vollenbröker; Daniela A Braun; Truc Van Le; Daniel Granado; Joachim Kremerskothen; Benjamin Fränzel; Rafael Klosowski; Johannes Barth; Christian Fufezan; Dirk A Wolters; Hermann Pavenstädt; Thomas Weide
Journal:  Mol Cell Proteomics       Date:  2014-02-27       Impact factor: 5.911

8.  The phosphoinositide kinase PIKfyve is vital in early embryonic development: preimplantation lethality of PIKfyve-/- embryos but normality of PIKfyve+/- mice.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Yufen Xie; Jian-Ping Jin; Daniel Rappolee; Assia Shisheva
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 9.  The role of phosphoinositides in synapse function.

Authors:  Yoshibumi Ueda
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

10.  Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Khortnal Delvecchio; Han-Zhong Feng; Gregory D Cartee; Jian-Ping Jin; Assia Shisheva
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.